Results 231 to 240 of about 617,141 (296)

Selective Absence of Co‐Inhibitory Receptor‐Expressing CD4+ T Cells in Lungs of Obese House Dust Mite‐Allergic C57BL/6 Mice

Allergy, EarlyView.
Obesity altered the inflammatory phenotype of HDM‐induced allergic airway inflammation in C57BL/6 mice, indicated by changed BAL cell composition. Single‐cell CITE‐Seq identified the lack of a CD4+ T‐cell subcluster characterized by co‐inhibitory receptor expression in obese HDM‐exposed C57BL/6 mice.
Sarah Miethe, Daniel P. Potaczek, Kim Pauck, Andrea Berlin, Bilal Alashkar Alhamwe, Stefanie Hagner, Andrea Nist, Elke Pogge von Strandmann, Thorsten Stiewe, Paul Klemm, Hartmann Raifer, Clemens Thölken, Holger Garn   +12 more
wiley   +1 more source

Orphan GPCRs in diabetes mellitus: metabolic control, inflammation, and drug development. [PDF]

Front Endocrinol (Lausanne)
Chandrabose S, Muniyandi V, Geddawy A, Thiyagarajan R, Murugesan A, Kandhavelu M.   +5 more
europepmc   +1 more source

Review Article: Fibrosis Reversal in Metabolic Dysfunction-Associated Steatohepatitis-The Promise of Emerging Therapeutics. [PDF]

Aliment Pharmacol Ther
Ayoub M, Tsutsumi T, Rinella ME.
europepmc   +1 more source

Recent advances in incretin biology and therapeutics: From glucose-dependent insulinotropic polypeptide reappraisal to next-generation agonists. [PDF]

J Diabetes Investig
Kubota S, Seino Y, Yabe D.
europepmc   +1 more source

GLP-1 and dual GIP/GLP-1 receptor agonists' psychopharmacology and putative neuropsychiatric associated effects: a Bradford Hill-informed, systematic, evaluation. [PDF]

Curr Psychiatry Rep
Schifano F, De Luca MA, Bonaccorso S, Arillotta D, Floresta G, Martinotti G, Papanti GD, Corkery JM, Chiappini S, Guirguis A.   +9 more
europepmc   +1 more source

Current and forthcoming pharmacotherapies for adolescent obesity: Evidence-based review. [PDF]

World J Clin Pediatr
Fuentes-Mendoza JM, Concepción-Zavaleta MJ, Dongo-Dueñas LG, Jara-Pianto JMJ, Sierra-Martel JA, Medina-Angulo CA, Virú-Flores HM, Mendoza-Godoy JJ, Zavaleta-Gutiérrez FE, Paz-Ibarra J.   +9 more
europepmc   +1 more source

GLP-1 (Glucagon-Like Peptide-1) and GIP (Glucose-Dependent Insulinotropic Polypeptide)/GLP-1 Receptor Agonists for Antipsychotic-Induced Weight Gain: A Narrative Review. [PDF]

Cureus
Buczkowska A, Glinski M, Danieluk J, Adamaszek N, Kacprzak U, Dolega-Mostowska D, Stochaj L, Flejszman M, Wojcik J, Sochowska J.   +9 more
europepmc   +1 more source

Glucagon receptors

Cellular and Molecular Life Sciences, 2008
Glucagon is a pancreatic peptide hormone that, as a counterregulatory hormone for insulin, stimulates glucose release by the liver and maintains glucose homeostasis. First described as a glucagon binding entity functionally linked to adenylyl cyclase, the glucagon receptor is a member of the family B receptors within the G protein coupled superfamily ...
Authier, François, Desbuquois, Bernard
openaire   +5 more sources